PTCH1 or SMO Activated Solid and Hematologic Tumors
1 clinical trials · Condition
◉ Watch PTCH1 or SMO Activated Solid and Hematologic Tumors
| Record | Firm | Date |
|---|---|---|
| LDE225 for Patients With PTCH1 or SMO Mutated Tumors (NCT02002689) | Novartis Pharmaceuticals | 2014-02-01 |
Track PTCH1 or SMO Activated Solid and Hematologic Tumors automatically
Every clearance here is in the API, with alerts when new ones post.